Tag: Biotech and Pharmaceuticals

Trump reaches deal with AstraZeneca to lower U.S. drug prices

Posted on By Admin No Comments on Trump reaches deal with AstraZeneca to lower U.S. drug prices

U.S. President Donald Trump participates in a bilateral meeting with Finland’s President Alexander Stubb (not pictured), in the Oval office at the White House in Washington, D.C., U.S., Oct. 9, 2025. Nathan Howard | Reuters The Trump administration and AstraZeneca announced Friday they have reached an agreement for the U.K.-based pharmaceutical giant to cut drug…

Read More “Trump reaches deal with AstraZeneca to lower U.S. drug prices” »

Health

CDC takes down more than a dozen webpages on sexual and gender identity, health equity

Posted on By Admin No Comments on CDC takes down more than a dozen webpages on sexual and gender identity, health equity

A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus in Atlanta, Georgia, U.S., May 30, 2025. Megan Varner | Reuters More than a dozen pages on the Centers for Disease Control and Prevention website related to sexual and gender identity, health equity, and other…

Read More “CDC takes down more than a dozen webpages on sexual and gender identity, health equity” »

Health

Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to its latest Watch

Posted on By Admin No Comments on Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to its latest Watch

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Food…

Read More “Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to its latest Watch” »

Health

Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

Posted on By Admin No Comments on Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial,…

Read More “Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors” »

Health

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Posted on By Admin No Comments on Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn’t until 2023 when she was diagnosed with…

Read More “Weight loss drugs could be a gamechanger for women with a common hormonal disorder” »

Health

Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

Posted on By Admin No Comments on Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

An aerial view of Valley Health Hampshire Memorial Hospital on June 17, 2025 in Romney, W.V. Ricky Carioti | The Washington Post | Getty Images President Donald Trump‘s “big beautiful bill” would make sweeping changes to U.S. health care, leaving millions of vulnerable Americans without health insurance and threatening the hospitals and centers that provide…

Read More “Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals” »

Health

Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access

Posted on By Admin No Comments on Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A wave of outrage is sweeping the scientific and medical world after Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to stop recommending routine Covid-19…

Read More “Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access” »

Health

Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

Posted on By Admin No Comments on Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S….

Read More “Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know ” »

Health

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Posted on By Admin No Comments on Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant’s weight loss drug Zepbound and its diabetes treatment Mounjaro, the company’s latest attempt to crack down on…

Read More “Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro” »

Health

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

Posted on By Admin No Comments on Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk.  Reuters President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. But the Centers…

Read More “Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound” »

Health